PATENT CLAIM ANALYSIS

Application Number: 16107605
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "293000"]

Abstract:
Disclosed are alkyl chain modified 1H-imidazoquinoline compounds, derivatives and analogs thereof, as Toll-like receptor-7 and -8 agonists for enhancing immune responses. Also provided are methods of making pharmaceutical compositions containing these compounds. The present disclosure also describes methods of use for the alkyl chain modified 1H-imidazoquinoline compounds, derivatives and analogs thereof, and pharmaceutical compositions containing these compounds for the treatment of disease in a subject.

Claim (Index 42):
A method of treating or preventing an infectious disease in a mammalian subject in need thereof, comprising administering to the mammalian subject the pharmaceutical composition of  claim 36  in an amount sufficient to treat the infectious disease in the mammalian subject.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 96.0
- Lexical Diversity: 1.67442
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15848349', '13475284', '14279416', '15793820', '13832179']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7897464620810102
- 35 USC 102 Novelty (BERT): 0.5253955240282929
- Combined Prediction Score: 0.7633113682757384
- Mean Citation Score: 308.7829920000001
- Max Citation Score: 313.4957
- Similarity Product: 166.91761524714823

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test